The UNC Eshelman School of Pharmacy offers a variety of fellowships sponsored by the NIH, pharmaceutical industry partners, and traditional academic-funded fellowships. Details regarding these fellowships are included under the following links:

Postdoctoral Fellowships Offered by the School
Postdoctoral Fellowships Offered by Divisions 
The Division of Pharmacotherapy and Experimental Therapeutics offers several two-year, industry-sponsored postdoctoral fellowships, as well as academic fellowships. Fellows gain extensive training and experience in developing, writing, managing, and enrolling patients into clinical studies, as well as scientific and grant writing, publications, and presentation skills. In addition, during the first year of their fellowships, fellows will take coursework related to their training program including, but not limited to, biostatistics, pharmacokinetics and pharmacogenomics.


Industry-Sponsored Fellowships

Clinical Research and Drug Development

Medical Affairs

Pharmacokinetics/Pharmacodynamics/Pharmacometrics

Global Regulatory Affairs


Academic Research Fellowships

Academic fellows spend the entire duration of their programs at UNC, focusing on clinical, preclinical and in vitro research projects.


DPET Current Fellows

History of the DPET Fellowship Program (PDF)

DPET Graduate/Fellowship Brochure (PDF)

Pharmaceutical Outcomes Research

The Pharmaceutical Outcomes Research fellowship provides support to Ph.D. students in their first and second years in the Division of Pharmaceutical Outcomes and Policy at the UNC Eshelman School of Pharmacy. This fellowship provides a competitive stipend, and provides health insurance, paid vacation, and compensation for travel to one professional meeting each year.

The University of North Carolina at Chapel Hill is an equal opportunity, affirmative action employer and welcomes all to apply regardless of race, color, gender, national origin, age, religion, genetic information, sexual orientation, gender identity or gender expression. We also encourage protected veterans and individuals with disabilities to apply.